NVP-016

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNVP-016
Drug Alias Namefourth generation cyclophilin inhibitors (Neurovive)NVP-016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidylprolyl isomerase inhibitors
TargetsPeptidylprolyl isomerase
Therapy Area/IndicationsMitochondrial DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbliva AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitopharm LtdAbliva AB
Active IndicationsN/A
Inactive IndicationsMitochondrial DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A